IOL CHEMICALS & PHARM. | ORCHID PHARMA | IOL CHEMICALS & PHARM./ ORCHID PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.5 | 42.4 | 31.7% | View Chart |
P/BV | x | 1.5 | 7.8 | 19.6% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. ORCHID PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
ORCHID PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ ORCHID PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 439 | 122.4% | |
Low | Rs | 272 | 273 | 99.7% | |
Sales per share (Unadj.) | Rs | 377.6 | 163.1 | 231.5% | |
Earnings per share (Unadj.) | Rs | 23.7 | 13.5 | 175.1% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 27.0 | 117.1% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 168.7 | 152.2% | |
Shares outstanding (eoy) | m | 58.71 | 40.82 | 143.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 2.2 | 49.1% | |
Avg P/E ratio | x | 17.1 | 26.3 | 64.9% | |
P/CF ratio (eoy) | x | 12.8 | 13.2 | 97.1% | |
Price / Book Value ratio | x | 1.6 | 2.1 | 74.7% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 14,522 | 163.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 654 | 257.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 6,659 | 333.0% | |
Other income | Rs m | 256 | 194 | 131.8% | |
Total revenues | Rs m | 22,427 | 6,853 | 327.2% | |
Gross profit | Rs m | 2,257 | 1,235 | 182.7% | |
Depreciation | Rs m | 462 | 548 | 84.3% | |
Interest | Rs m | 165 | 329 | 50.1% | |
Profit before tax | Rs m | 1,887 | 552 | 341.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 0 | - | |
Profit after tax | Rs m | 1,391 | 552 | 251.9% | |
Gross profit margin | % | 10.2 | 18.5 | 54.9% | |
Effective tax rate | % | 26.2 | 0 | - | |
Net profit margin | % | 6.3 | 8.3 | 75.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 5,010 | 192.9% | |
Current liabilities | Rs m | 5,025 | 3,719 | 135.1% | |
Net working cap to sales | % | 20.9 | 19.4 | 108.0% | |
Current ratio | x | 1.9 | 1.3 | 142.8% | |
Inventory Days | Days | 43 | 57 | 75.4% | |
Debtors Days | Days | 8 | 1,180 | 0.7% | |
Net fixed assets | Rs m | 11,017 | 7,242 | 152.1% | |
Share capital | Rs m | 587 | 408 | 143.8% | |
"Free" reserves | Rs m | 14,490 | 6,478 | 223.7% | |
Net worth | Rs m | 15,077 | 6,886 | 218.9% | |
Long term debt | Rs m | 0 | 1,488 | 0.0% | |
Total assets | Rs m | 20,684 | 12,252 | 168.8% | |
Interest coverage | x | 12.5 | 2.7 | 464.9% | |
Debt to equity ratio | x | 0 | 0.2 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.5 | 197.2% | |
Return on assets | % | 7.5 | 7.2 | 104.6% | |
Return on equity | % | 9.2 | 8.0 | 115.0% | |
Return on capital | % | 13.6 | 10.5 | 129.3% | |
Exports to sales | % | 26.7 | 81.9 | 32.7% | |
Imports to sales | % | 0 | 37.6 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 5,452 | 108.8% | |
Imports (cif) | Rs m | NA | 2,501 | 0.0% | |
Fx inflow | Rs m | 5,930 | 5,452 | 108.8% | |
Fx outflow | Rs m | 6,052 | 2,726 | 222.0% | |
Net fx | Rs m | -122 | 2,726 | -4.5% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 183 | 666.8% | |
From Investments | Rs m | -1,200 | -312 | 384.4% | |
From Financial Activity | Rs m | -41 | 312 | -13.2% | |
Net Cashflow | Rs m | -18 | 183 | -10.1% |
Indian Promoters | % | 48.2 | 69.8 | 69.0% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 19.7 | 8.6% | |
FIIs | % | 1.4 | 2.0 | 71.4% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 30.2 | 171.8% | |
Shareholders | 130,003 | 36,720 | 354.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Orchid Pharma | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.04% | 0.90% | -0.26% |
1-Month | 4.14% | -0.38% | 0.38% |
1-Year | -0.84% | 177.98% | 52.64% |
3-Year CAGR | -13.40% | -13.19% | 14.15% |
5-Year CAGR | 15.98% | 186.72% | 19.20% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Orchid Pharma share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Orchid Pharma the stake stands at 69.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Orchid Pharma.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Orchid Pharma paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Orchid Pharma.
For a sector overview, read our pharmaceuticals sector report.
Asian markets traded higher on Tuesday following overnight gain on Wall Street.